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Persons with severe burns often require transplantation of large skin grafts for their survival. 
Previous attempts to engineer artificial skin or tissue in vitro have been ineffective, and grafting of 
one’s own skin from one site to another is confined to small patches of skin and can have severe 
complications. Allogenic skin could meet the needs for large amounts of grafting material; however, 
because these allografts are obtained from genetically non-identical people they are acutely 
rejected. While immunosuppressive agents can prevent the early rejection of organ transplants such 
as the kidney and pancreas, they have been ineffective against skin, which is highly immunogenic. 
Thus, strategies to induce immune tolerance to skin allografts in the absence of chronic widespread 
immunosuppression are necessary. To address this need, Dr. David Mathes and colleagues in the 
Clinical Research Division have recently established a non-myeloablative conditioning regimen in a 
canine model that allows for engraftment of a multi-tissue vacularized skin graft. Furthermore, the 
resulting mixed chimerism of host and donor hematopoietic cells was stable and associated with 
locally increased numbers of FoxP3+ regulatory T-cells that mediate immune tolerance. 
Mixed host-donor chimerism was established in dogs by giving a sublethal dose of total body 
irradiation followed by hematopoietic cell transplantation and a short-term regimen of 
immunosuppressive therapy. Following confirmation of stable mixed chimerism, which took 
anywhere from five months to more than four years, the authors transplanted composite tissue grafts 
from the bone marrow donors to their respective recipients, and vice versa. Composite allografts 
allow for the evaluation of tolerance to multiple different tissues, as they are comprised of skin, 
muscle, fat, nerves and lymphatic and blood vessels. Composite allografts are an excellent 
transplantation model for complex tissues involving skin and muscle. While non-chimeric controls 
rejected grafts within 29 days, chimeric recipients accepted grafts ranging from 52-90 weeks. 
Acceptance was indicated by normal skin color and hair growth, normal blood cell counts, and 
histological absence of cellular infiltrates, vascular disease, or epidermal architecture damage within 
the graft region. Rejected grafts from control donors were marked by tissue necrosis and infiltrating 
effector T-cells. In contrast, skin, muscle and draining lymph nodes of chimeric recipients had 
increased frequencies of FoxP3+ regulatory T-cells. Regulatory T-cells are a subpopulation of the 
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immune system that suppresses the function of other immune cells to prevent autoimmune disease, 
maintain tolerance to self-antigens, and facilitate organ transplantation. 
This study demonstrates durable tolerance to all portions of a vascularized composite allograft in an 
out-bred dog population following a non-myeloablative conditioning regimen and short-term 
immunosuppressive treatment. It remains to be seen if these methods will be applicable to severe 
burn patients, who require rapid and extensive skin or composite tissue grafting. However, the 
methods developed in this study may obviate the need for long-term immunosuppressives in other 
less immunogenic and more commonly transplanted organs. 
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Pearson Education 
Multiple tissues make up a composite skin graft. 
 
